Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data

Background: The most important pathomechanism of <i>Clostridioides difficile</i> infections (CDI) is post-antibiotic intestinal dysbiosis. CDI affects both ambulatory and hospital patients. Aim: The objective of the study was to analyze the possibility of utilizing databases from the Eur...

Full description

Bibliographic Details
Main Authors: Estera Jachowicz, Anna Różańska, Monika Pobiega, Mariusz Topolski, Jadwiga Wójkowska-Mach
Format: Article
Language:English
Published: MDPI AG 2020-03-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/3/127
_version_ 1811322894164164608
author Estera Jachowicz
Anna Różańska
Monika Pobiega
Mariusz Topolski
Jadwiga Wójkowska-Mach
author_facet Estera Jachowicz
Anna Różańska
Monika Pobiega
Mariusz Topolski
Jadwiga Wójkowska-Mach
author_sort Estera Jachowicz
collection DOAJ
description Background: The most important pathomechanism of <i>Clostridioides difficile</i> infections (CDI) is post-antibiotic intestinal dysbiosis. CDI affects both ambulatory and hospital patients. Aim: The objective of the study was to analyze the possibility of utilizing databases from the European Centre for Disease Prevention and Control subject to surveillance for the purpose of identifying areas that require intervention with respect to public health. Methods: The analysis encompassed data concerning CDI incidence and antibiotic consumption expressed as defined daily doses (DDD) and quality indicators for antimicrobial-consumption involving both ambulatory and hospital patients in 2016. Results: In 2016, in the European Union countries, total antibiotic consumption in hospital and outpatient treatment amounted to 20.4 DDD (SD 7.89, range 11.04&#8722;39.69); in ambulatory treatment using average of ten times more antibiotics than hospitals. In total, 44.9% of antibiotics used in outpatient procedures were broad-spectrum antibiotics. We have found a significant relationship between the quality of antibiotics and their consumption: The more broad-spectrum antibiotics prescribed, the higher the sales of antibiotics both in the community sector and in total. CDI incidence did not statistically significantly correlate with the remaining factors analyzed on a country-wide level. Conclusion: Antibiotic consumption and the CDI incidence may depend on many national variables associated with local systems of healthcare organization and financing. Their interpretation in international comparisons does not give clear-cut answers and requires caution.
first_indexed 2024-04-13T13:44:18Z
format Article
id doaj.art-1be5a5a1205f4205b09b88d3280b255e
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-04-13T13:44:18Z
publishDate 2020-03-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-1be5a5a1205f4205b09b88d3280b255e2022-12-22T02:44:31ZengMDPI AGAntibiotics2079-63822020-03-019312710.3390/antibiotics9030127antibiotics9030127Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC DataEstera Jachowicz0Anna Różańska1Monika Pobiega2Mariusz Topolski3Jadwiga Wójkowska-Mach4Department of Microbiology, Faculty of Medicine, Jagiellonian University Collegium Medicum, 31-121 Kraków, PolandDepartment of Microbiology, Faculty of Medicine, Jagiellonian University Collegium Medicum, 31-121 Kraków, PolandDepartment of Microbiology, Faculty of Medicine, Jagiellonian University Collegium Medicum, 31-121 Kraków, PolandDepartment of Systems and Computer Networks, Wroclaw University of Science and Technology, 50-370 Wroclaw, PolandDepartment of Microbiology, Faculty of Medicine, Jagiellonian University Collegium Medicum, 31-121 Kraków, PolandBackground: The most important pathomechanism of <i>Clostridioides difficile</i> infections (CDI) is post-antibiotic intestinal dysbiosis. CDI affects both ambulatory and hospital patients. Aim: The objective of the study was to analyze the possibility of utilizing databases from the European Centre for Disease Prevention and Control subject to surveillance for the purpose of identifying areas that require intervention with respect to public health. Methods: The analysis encompassed data concerning CDI incidence and antibiotic consumption expressed as defined daily doses (DDD) and quality indicators for antimicrobial-consumption involving both ambulatory and hospital patients in 2016. Results: In 2016, in the European Union countries, total antibiotic consumption in hospital and outpatient treatment amounted to 20.4 DDD (SD 7.89, range 11.04&#8722;39.69); in ambulatory treatment using average of ten times more antibiotics than hospitals. In total, 44.9% of antibiotics used in outpatient procedures were broad-spectrum antibiotics. We have found a significant relationship between the quality of antibiotics and their consumption: The more broad-spectrum antibiotics prescribed, the higher the sales of antibiotics both in the community sector and in total. CDI incidence did not statistically significantly correlate with the remaining factors analyzed on a country-wide level. Conclusion: Antibiotic consumption and the CDI incidence may depend on many national variables associated with local systems of healthcare organization and financing. Their interpretation in international comparisons does not give clear-cut answers and requires caution.https://www.mdpi.com/2079-6382/9/3/127<i>clostridioides difficile</i>healthcare-associated infectionsantibiotic consumptionstatistical methods of data classification
spellingShingle Estera Jachowicz
Anna Różańska
Monika Pobiega
Mariusz Topolski
Jadwiga Wójkowska-Mach
Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data
Antibiotics
<i>clostridioides difficile</i>
healthcare-associated infections
antibiotic consumption
statistical methods of data classification
title Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data
title_full Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data
title_fullStr Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data
title_full_unstemmed Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data
title_short Consumption of Antibiotics and Epidemiology of <i>Clostridioides difficile</i> in the European Union in 2016—Opportunity for Practical Application of Aggregate ECDC Data
title_sort consumption of antibiotics and epidemiology of i clostridioides difficile i in the european union in 2016 opportunity for practical application of aggregate ecdc data
topic <i>clostridioides difficile</i>
healthcare-associated infections
antibiotic consumption
statistical methods of data classification
url https://www.mdpi.com/2079-6382/9/3/127
work_keys_str_mv AT esterajachowicz consumptionofantibioticsandepidemiologyoficlostridioidesdifficileiintheeuropeanunionin2016opportunityforpracticalapplicationofaggregateecdcdata
AT annarozanska consumptionofantibioticsandepidemiologyoficlostridioidesdifficileiintheeuropeanunionin2016opportunityforpracticalapplicationofaggregateecdcdata
AT monikapobiega consumptionofantibioticsandepidemiologyoficlostridioidesdifficileiintheeuropeanunionin2016opportunityforpracticalapplicationofaggregateecdcdata
AT mariusztopolski consumptionofantibioticsandepidemiologyoficlostridioidesdifficileiintheeuropeanunionin2016opportunityforpracticalapplicationofaggregateecdcdata
AT jadwigawojkowskamach consumptionofantibioticsandepidemiologyoficlostridioidesdifficileiintheeuropeanunionin2016opportunityforpracticalapplicationofaggregateecdcdata